Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia
International Journal of Neonatal Screening · 14.11.2025 · 11 (4) · 107
DOI: 10.3390/ijns11040107 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 14.11.2025. Verfasst von Houyem Ouragini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular and Cellular Hematology, LR16IPT07, Institut Pasteur de Tunis, University of Tunis ElManar, Tunis 1002, Tunisia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tunisian Ministry of Higher Education and Scientific Research.
Abstract (Originalsprache)
Hemoglobinopathies represent a major public health concern in Tunisia. Although early diagnosis is essential, systemic neonatal screening has not yet been implemented at the national level. We conducted a screening study in Northern Tunisia (Bizerte region) using cord blood samples. Complete blood counts and hemoglobin analysis by capillary electrophoresis were performed. Samples showing abnormal profiles (HbBart’s, HbS, HbC, or HbA < 20%) underwent molecular testing. Correlations between hematological parameters, hemoglobin fractions, and β mutation types were assessed. Among 328 neonatal cord blood samples analyzed, we detected 3 silent α+-thalassemia, 6 β+-thalassemia traits, 3 β0-thalassemia traits, 7 HbS traits, 2 HbC traits, and 1 compound heterozygous for α+-thalassemia/HbC. No homozygous cases were identified. The heterozygous frequency was estimated at 1.2%, 2.7%, and 2.1% for α-thalassemia, β-thalassemia, and sickle cell disease, respectively. HbF levels were significantly associated with the β-thalassemia trait. This study represents the first hemoglobinopathy screening in Northern Tunisia using cord blood, highlighting the feasibility and reliability of this approach. While pilot programs have already been initiated in some regions, our findings reinforce the need for broader implementation to ensure early and accurate diagnosis across the country.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular and Cellular Hematology, LR16IPT07, Institut Pasteur de Tunis, University of Tunis ElManar, Tunis 1002, Tunisia.
- Laboratory of Physiopathology, Alimentation and Biomolecules, LR17ES03, Higher Institute of Biotechnology, Sidi Thabet, University of Manouba, Ariana 2020, Tunisia.
- Department of Gynecology and Obstetrics, Habib Bougatfa Hospital, Bizerte 7000, Tunisia.
ORCID-Profile: Houyem Ouragini
Förderung
- Tunisian Ministry of Higher Education and Scientific Research
Zitieren
APA
Ouragini, H., Halim, N. B., Zitouni, S., Chaouachi, D., Boudrigua, I., Saidani, N., Kraiem, I., Ayachi, A., Abbes, S., Mourali, M., & Menif, S. (2025). Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia. International Journal of Neonatal Screening, 11(4), 107. https://doi.org/10.3390/ijns11040107
Vancouver
Ouragini H, Halim NB, Zitouni S, Chaouachi D, Boudrigua I, Saidani N, et al. Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia. International Journal of Neonatal Screening. 2025;11(4):107. doi:10.3390/ijns11040107
BibTeX
@article{Ouragini2025,
author = {Ouragini, Houyem and Halim, Nizar Ben and Zitouni, Sana and Chaouachi, Dorra and Boudrigua, Imen and Saidani, Naima and Kraiem, Imen and Ayachi, Amira and Abbes, Salem and Mourali, Mechaal and Menif, Samia},
title = {Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia},
journal = {International Journal of Neonatal Screening},
year = {2025},
volume = {11},
number = {4},
pages = {107},
doi = {10.3390/ijns11040107}
}
EUVIMED